AI Article Synopsis

  • Regular physical exercise may offer protective benefits against chronic kidney disease (CKD) by improving kidney function and reducing oxidative stress.
  • The study involved 24 male Wistar rats divided into four groups, where the 5/6 nephrectomized rats that exercised showed significant improvements in various health markers compared to their non-exercising counterparts.
  • Results indicated that exercise not only enhanced renal health but also increased levels of hydrogen sulfide (H2S) in the kidneys, suggesting a potential link between exercise, H2S levels, and kidney protection.

Article Abstract

Physical exercise is shown to have protective effects on chronic kidney disease (CKD). CKD itself is associated with a reduction in renal hydrogen sulfide (H2S) concentration. This study was designed to investigate whether protective effects of exercise in 5/6 nephrectomized (5/6 NX) rats is associated with H2S levels in the kidney? Twenty four male Wistar rats weighing 250-300 g were assigned into 4 groups: 1- Sham 2- Sham exercise 3-5/6 NX 4-5/6 NX+exercise. To induce CKD, 4 days after removing upper and lower one-third parts of the left kidney, total right nephrectomy was performed. In the Sham groups, anesthesia and surgery were performed like the other groups without removal of the kidney mass. Exercise was performed by treadmill at a speed of 18 m/min for 8 weeks. At the end of the twelfth week, blood and kidney samples were collected to measure renal function (levels of plasma urea and creatinine), oxidative stress markers (renal MDA level and SOD activity), and histological indices. Eight weeks exercise significantly improved serum creatinine, BUN, renal MDA level, SOD activity, renal sympathetic nerve activity (RSNA), hypertension, and renal histology in addition to renal H2S level compared to the 5/6 NX group. The results suggest that regular exercise improves renal oxidative status and ameliorates renal damage, hypertension, and RSNA in 5/6 nephrectomized rats. These improvements by exercise might be associated with the increase in renal H2S level.

Download full-text PDF

Source
http://dx.doi.org/10.1080/10641963.2018.1445752DOI Listing

Publication Analysis

Top Keywords

5/6 nephrectomized
12
renal
10
hydrogen sulfide
8
exercise
8
nephrectomized rats
8
protective effects
8
renal mda
8
mda level
8
level sod
8
sod activity
8

Similar Publications

sGC stimulator (BAY 41-8543) combined with PDE9 inhibitor (BAY 73-6691) reduces renal fibrosis in 5/6 nephrectomized rats.

Basic Clin Pharmacol Toxicol

January 2025

Fifth Department of Medicine (Nephrology/Endocrinology/Rheumatology/Pneumology), University Medical Centre Mannheim, University of Heidelberg, Germany.

Renal fibrosis is closely related to the prognosis of chronic kidney disease (CKD). The increase in cGMP reduces renal fibrosis. Soluble guanylate cyclase (sGC) and phosphodiesterase (PDE) are key enzymes that maintain cGMP levels.

View Article and Find Full Text PDF

Comparison of sGC activator and sGC stimulator in 5/6 nephrectomized rats on high-salt-diet.

Front Pharmacol

October 2024

Fifth Department of Medicine (Nephrology/Endocrinology/Rheumatology/Pneumology), University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany.

Article Synopsis
  • Soluble guanylate cyclase (sGC) stimulators and activators potentially improve kidney function in chronic kidney disease (CKD) models by boosting levels of cyclic guanosine monophosphate (cGMP), but their effects during oxidative stress hadn't been compared previously.
  • A study compared the effects of two compounds, BAY 41-8543 (an sGC stimulator) and BAY 60-2770 (an sGC activator), on CKD progression in rats with significant kidney damage on a high salt diet over 11 weeks.
  • While both compounds lowered blood pressure, only BAY 60-2770 effectively reduced kidney fibrosis and improved outcomes related to proteins tied to fibrosis and apoptosis, indicating that sGC
View Article and Find Full Text PDF
Article Synopsis
  • * Using animal models and cell cultures, the research shows that IS negatively affects tight junction proteins, increases cell death, and disrupts cellular functions, while RSV counters these effects by preserving tight junction integrity and promoting cell survival mechanisms.
  • * The findings suggest that RSV could serve as a therapeutic option for CKD by improving intestinal barrier function and regulating cellular processes, offering a deeper understanding of its role in managing CKD
View Article and Find Full Text PDF
Article Synopsis
  • Recent research shows that SLC5A2/SGLT2 inhibitors, like empagliflozin, offer kidney protection in non-diabetic chronic kidney disease (CKD) without clear signs of albuminuria, yet the mechanism of this effect remains unclear.
  • The study used various mouse models, including those with obesity and kidney injury, and found that empagliflozin reduced harmful effects like lipotoxicity, inflammation, and fibrosis in kidney tubules by lowering intraglomerular pressure.
  • Empagliflozin also decreased albumin reabsorption, improved autophagic processes, and lessened the risk of kidney injury, suggesting that enhancing autophagy is key to the protective effects
View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to evaluate the protective effects of the Shenshuai recipe (SSR) on myocardial injury in chronic kidney disease (CKD) by analyzing the role of the PINK1/Parkin mitochondrial autophagy pathway.
  • - Forty-eight nephrectomized rats were divided into groups for different treatments, including control and SSR, and were monitored for changes in cardiac function, biochemical markers, and myocardial tissue characteristics over six weeks.
  • - Results showed SSR improved heart function, reduced harmful enzyme levels, and enhanced autophagy markers in the myocardium, indicating its potential as a treatment for CKD-related heart injuries.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!